The world’s second-largest automaker plans to halve its lineup of cars as part of its second major overhaul in two years.

The Democratic Socialists of America group has a handful of members poised for victory in the midterms.

Western biotechs are getting a new playbook with tighter controls to stay ahead of an ultraefficient pharmaceutical pipeline ...

Fidji Simo won’t return from medical leave, leaving a major role to fill as the AI giant prepares to go public.

Moscow’s new dilemma is how to protect a much bigger geographic area with limited air-defense capabilities.

He hails Toyota’s investment, but what about the higher costs and manufacturing job losses?

Boosted by a legal win for the Trumps, a Schwab account went on an automated trading spree.

The South Korean chip maker’s debut on Wall Street is set to be the largest share sale by a non-U.S. company after it raised ...

Democrats have until July 27 to fine a new Senate candidate in Maine and no one is sure what comes next.

The asset-management firm agreed to buy a minority stake in Bayer’s long-acting reversible contraceptives business.

The streamer is rethinking some of its core strategies to compete with rivals.